First National Bank of South Miami’s Vertex Pharmaceuticals VRTX Stock Holding History

First National Bank of South Miami’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-62	Closed	-$19.5K	–	265
2023 Q1	$19.5K	Hold	62	–	–	0.02%	222
2022 Q4	$18K	Sell	62 -10	-14%	-$3.05K	0.01%	227
2022 Q3	$21K	Sell	72 -27	-27%	-$7.77K	0.02%	224
2022 Q2	$28K	Sell	99 -43	-30%	-$11.5K	0.02%	228
2022 Q1	$37K	Sell	142 -20	-12%	-$4.75K	0.02%	232
2021 Q4	$36K	Sell	162 -35	-18%	-$6.81K	0.02%	239
2021 Q3	$36K	Buy	197 +33	+20%	+$6.44K	0.02%	233
2021 Q2	$33K	Sell	164 -80	-33%	-$16.7K	0.02%	230
2021 Q1	$52K	Buy	+244	New	+$53.6K	0.04%	190

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First National Bank of South Miami's VRTX Position: Q2 2023 in Review

First National Bank of South Miami sold out of Vertex Pharmaceuticals (VRTX) in Q2 2023, closing a stake of 62 shares — an estimated $19.5K sold.

First National Bank of South Miami first reported a position in VRTX in Q1 2021 and held it in 9 quarters. The position peaked at $52K in Q1 2021. 1,286 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

First National Bank of South Miami reported no remaining Vertex Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
First National Bank of South Miami sold 62 Vertex Pharmaceuticals shares in Q2 2023, an estimated $19.5K.
First National Bank of South Miami first reported a position in Vertex Pharmaceuticals in Q1 2021 and held it in 9 quarters.
First National Bank of South Miami's Vertex Pharmaceuticals position peaked at $52K in Q1 2021.
1,286 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.